 | • レポートコード：MRC2305C038 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、229ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界の治療用呼吸装置市場規模が2021年に139.8億ドル、2022年に160.7億ドルとなり、更に年平均15.22％成長して2027年には327.2億ドルに達すると予測しています。当市場調査レポートでは、治療用呼吸装置の世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品タイプ別分析（カプノグラフ、ガス分析装置、加湿器、ネブライザー、酸素濃縮器）、技術別分析（静電ろ過、HEPAフィルター技術、中空糸ろ過、ミクロスフェア分離）、用途別分析（喘息、慢性閉塞性肺疾患（COPD）、嚢胞性線維症、閉塞性睡眠時無呼吸、呼吸窮迫症候群）、最終用途別分析（救急センター、在宅医療、病院）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの内容を掲載しています。なお、当書には、Becton, Dickinson and Company、BMC Medical Co., Ltd.、CAIRE Inc.、Chart Industries, Inc.、Compumedics Limited.、Drägerwerk AG & Co. KGaA、Fisher & Paykel Healthcare Limited、GE Healthcare、Hamilton Medical AG、ICU Medical, Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の治療用呼吸装置市場規模：製品タイプ別 - カプノグラフの市場規模 - ガス分析装置の市場規模 - 加湿器の市場規模 - ネブライザーの市場規模 - 酸素濃縮器の市場規模 ・世界の治療用呼吸装置市場規模：技術別 - 静電ろ過の市場規模 - HEPAフィルター技術の市場規模 - 中空糸ろ過の市場規模 - ミクロスフェア分離の市場規模 ・世界の治療用呼吸装置市場規模：用途別 - 喘息における市場規模 - 慢性閉塞性肺疾患（COPD）における市場規模 - 嚢胞性線維症における市場規模 - 閉塞性睡眠時無呼吸における市場規模 - 呼吸窮迫症候群における市場規模 ・世界の治療用呼吸装置市場規模：最終用途別 - 救急センターにおける市場規模 - 在宅医療における市場規模 - 病院における市場規模 ・世界の治療用呼吸装置市場規模：地域別 - 南北アメリカの治療用呼吸装置市場規模 アメリカの治療用呼吸装置市場規模 カナダの治療用呼吸装置市場規模 ブラジルの治療用呼吸装置市場規模 ... - アジア太平洋の治療用呼吸装置市場規模 日本の治療用呼吸装置市場規模 中国の治療用呼吸装置市場規模 インドの治療用呼吸装置市場規模 韓国の治療用呼吸装置市場規模 台湾の治療用呼吸装置市場規模 ... - ヨーロッパ/中東/アフリカの治療用呼吸装置市場規模 イギリスの治療用呼吸装置市場規模 ドイツの治療用呼吸装置市場規模 フランスの治療用呼吸装置市場規模 ロシアの治療用呼吸装置市場規模 ... - その他地域の治療用呼吸装置市場規模 ・競争状況 ・企業情報 |
The Global Therapeutic Respiratory Devices Market size was estimated at USD 13.98 billion in 2021 and expected to reach USD 16.07 billion in 2022, and is projected to grow at a CAGR 15.22% to reach USD 32.72 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Therapeutic Respiratory Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Capnographs, Gas Analyzers, Humidifiers, Nebulizers, Oxygen Concentrators, Positive Airway Pressure Devices, and Ventilators. The Humidifiers is further studied across Built-In Humidifiers, Heated Humidifiers, Integrated Humidifiers, Passover Humidifiers, and Stand-Alone Humidifiers. The Nebulizers is further studied across Compressor-Based Nebulizers, Piston-Based Hand-Held Nebulizers, and Ultrasonic Nebulizers. The Oxygen Concentrators is further studied across Fixed Oxygen Concentrators and Portable Oxygen Concentrators. The Positive Airway Pressure Devices is further studied across Auto-Titrating Positive Airway Pressure Devices, Bi-Level Positive Airway Pressure Devices, and Continuous Positive Airway Pressure Devices. The Ventilators is further studied across Adult Ventilators and Neonatal Ventilators.
Based on Technology, the market was studied across Electrostatic filtration, HEPA filter technology, Hollow fiber filtration, and Microsphere Separation.
Based on Application, the market was studied across Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Obstructive Sleep Apnea, and Respiratory Distress Syndrome.
Based on End-Use, the market was studied across Emergency Centers, Homecare Settings, and Hospital.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Therapeutic Respiratory Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Therapeutic Respiratory Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Therapeutic Respiratory Devices Market, including Becton, Dickinson and Company, BMC Medical Co., Ltd., CAIRE Inc., Chart Industries, Inc., Compumedics Limited., Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, GE Healthcare, Hamilton Medical AG, ICU Medical, Inc., Inogen, Inc., Invacare Corporation, Koninklijke Philips N.V., Medtronic PLC, Nidek Medical Products, Inc, Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare, Teleflex Incorporated, and Vyaire Medical, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Therapeutic Respiratory Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Therapeutic Respiratory Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Therapeutic Respiratory Devices Market?
4. What is the competitive strategic window for opportunities in the Global Therapeutic Respiratory Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Therapeutic Respiratory Devices Market?
6. What is the market share of the leading vendors in the Global Therapeutic Respiratory Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Therapeutic Respiratory Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of respiratory diseases among geriatric population
5.1.1.2. Rapid development of portable, efficient, and superior respiratory devices
5.1.1.3. Increasing healthcare awareness along with improving healthcare infrastructure
5.1.2. Restraints
5.1.2.1. Stringent regulations on device approvals
5.1.3. Opportunities
5.1.3.1. Introduction of real-time respiratory monitoring devices
5.1.3.2. Increasing application in-home care setting
5.1.4. Challenges
5.1.4.1. Patients face challenge with continuous device usability
5.2. Cumulative Impact of COVID-19
6. Therapeutic Respiratory Devices Market, by Product Type
6.1. Introduction
6.2. Capnographs
6.3. Gas Analyzers
6.4. Humidifiers
6.5.1. Built-In Humidifiers
6.5.2. Heated Humidifiers
6.5.3. Integrated Humidifiers
6.5.4. Passover Humidifiers
6.5.5. Stand-Alone Humidifiers
6.5. Nebulizers
6.6.1. Compressor-Based Nebulizers
6.6.2. Piston-Based Hand-Held Nebulizers
6.6.3. Ultrasonic Nebulizers
6.6. Oxygen Concentrators
6.7.1. Fixed Oxygen Concentrators
6.7.2. Portable Oxygen Concentrators
6.7. Positive Airway Pressure Devices
6.8.1. Auto-Titrating Positive Airway Pressure Devices
6.8.2. Bi-Level Positive Airway Pressure Devices
6.8.3. Continuous Positive Airway Pressure Devices
6.8. Ventilators
6.9.1. Adult Ventilators
6.9.2. Neonatal Ventilators
7. Therapeutic Respiratory Devices Market, by Technology
7.1. Introduction
7.2. Electrostatic filtration
7.3. HEPA filter technology
7.4. Hollow fiber filtration
7.5. Microsphere Separation
8. Therapeutic Respiratory Devices Market, by Application
8.1. Introduction
8.2. Asthma
8.3. Chronic Obstructive Pulmonary Disease (COPD)
8.4. Cystic Fibrosis
8.5. Obstructive Sleep Apnea
8.6. Respiratory Distress Syndrome
9. Therapeutic Respiratory Devices Market, by End-Use
9.1. Introduction
9.2. Emergency Centers
9.3. Homecare Settings
9.4. Hospital
10. Americas Therapeutic Respiratory Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Therapeutic Respiratory Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Therapeutic Respiratory Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Becton, Dickinson and Company
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. BMC Medical Co., Ltd.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. CAIRE Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Chart Industries, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Compumedics Limited.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Drägerwerk AG & Co. KGaA
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Fisher & Paykel Healthcare Limited
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. GE Healthcare
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Hamilton Medical AG
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. ICU Medical, Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Inogen, Inc.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Invacare Corporation
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Koninklijke Philips N.V.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Medtronic PLC
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Nidek Medical Products, Inc
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Nihon Kohden Corporation
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Siemens Healthcare
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Teleflex Incorporated
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Vyaire Medical, Inc.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing